» Articles » PMID: 35934688

Non-alcoholic Fatty Liver Disease: a Multi-system Disease Influenced by Ageing and Sex, and Affected by Adipose Tissue and Intestinal Function

Overview
Journal Proc Nutr Soc
Date 2022 Aug 7
PMID 35934688
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, a wealth of factors are associated with increased risk of developing non-alcoholic fatty liver disease (NAFLD) and NAFLD is now thought to increase the risk of multiple extra-hepatic diseases. The aim of this review is first to focus on the role of ageing and sex as key, poorly understood risk factors in the development and progression of NAFLD. Secondly, we aim to discuss the roles of white adipose tissue (WAT) and intestinal dysfunction, as producers of extra-hepatic factors known to further contribute to the pathogenesis of NAFLD. Finally, we aim to summarise the role of NAFLD as a multi-system disease affecting other organ systems beyond the liver. Both increased age and male sex increase the risk of NAFLD and this may be partly driven by alterations in the distribution and function of WAT. Similarly, changes in gut microbiota composition and intestinal function with ageing and chronic overnutrition are likely to contribute to the development of NAFLD both directly (i.e. by affecting hepatic function) and indirectly via exacerbating WAT dysfunction. Consequently, the presence of NAFLD significantly increases the risk of various extra-hepatic diseases including CVD, type 2 diabetes mellitus, chronic kidney disease and certain extra-hepatic cancers. Thus changes in WAT and intestinal function with ageing and chronic overnutrition contribute to the development of NAFLD - a multi-system disease that subsequently contributes to the development of other chronic cardiometabolic diseases.

Citing Articles

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Orfanidou M, Polyzos S Medicina (Kaunas). 2025; 61(1).

PMID: 39859020 PMC: 11766779. DOI: 10.3390/medicina61010038.


Prevalence and characteristics of liver steatosis and fibrosis in type 2 diabetes mellitus (T2DM) patients: a cross-sectional study in populations of eastern China.

Yu H, Su X, Tao W, Sun W, Zhang X, Han Q BMJ Open. 2024; 14(12):e087550.

PMID: 39672583 PMC: 11647396. DOI: 10.1136/bmjopen-2024-087550.


Can salivary and skin microbiome become a biodetector for aging-associated diseases? Current insights and future perspectives.

Nurkolis F, Utami T, Alatas A, Wicaksono D, Kurniawan R, Ratmandhika S Front Aging. 2024; 5:1462569.

PMID: 39484071 PMC: 11524912. DOI: 10.3389/fragi.2024.1462569.


Extra Virgin Olive Oil Reduces the Risk of Non-Alcoholic Fatty Liver Disease in Females but Not in Males: Results from the NUTRIHEP Cohort.

Donghia R, Tatoli R, Campanella A, Losurdo G, Di Leo A, De Pergola G Nutrients. 2024; 16(19).

PMID: 39408202 PMC: 11478343. DOI: 10.3390/nu16193234.


Female obesity: clinical and psychological assessment toward the best treatment.

Guglielmi V, Dalle Grave R, Leonetti F, Solini A Front Endocrinol (Lausanne). 2024; 15:1349794.

PMID: 38765954 PMC: 11099266. DOI: 10.3389/fendo.2024.1349794.